Sign in or Register   Sign in or Register
  |  

Mouse Anti-CSNK2B Recombinant Antibody (CBXC-2709) (CBMAB-C0079-CQ)

This product is a mouse antibody that recognizes CSNK2B. The antibody CBXC-2709 can be used for immunoassay techniques such as: WB, FC, ELISA, CyTOF.
See all CSNK2B antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBXC-2709
Antibody Isotype
IgG
Application
WB, FC, ELISA, CyTOF

Basic Information

Immunogen
Purified recombinant fragment of human CSNK2B (AA: FULL(1-215)) expressed in E. coli
Specificity
Human
Antibody Isotype
IgG
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Casein Kinase 2 Beta
Introduction
CSNK2B (Casein Kinase 2 Beta) is a Protein Coding gene. Diseases associated with CSNK2B include Autosomal Dominant Non-Syndromic Intellectual Disability and Egg Allergy. Among its related pathways are Mitotic Prometaphase and Mitophagy - animal. Gene Ontology (GO) annotations related to this gene include identical protein binding and receptor binding.
Entrez Gene ID
1460
UniProt ID
P67870
Alternative Names
Casein Kinase 2 Beta; Casein Kinase 2, Beta Polypeptide; Protein G5a; CK II Beta; Phosvitin; CK2N; G5A; Casein Kinase II B Subunit Splicing Isoform 132; Casein Kinase II B Subunit Splicing Isoform 247; Casein Kinase II B Subunit Splicing Isoform 318; Casein Kinase II B Subunit Splicing Isoform 660; Casein Kinase II B Subunit Splicing Isoform 806; Chimera CSNK2B-LY6G5B Splicing Isoform 1072; Chimera CSNK2B-LY6G5B Splicing Isoform 1103; Chimera CSNK2B-LY6G5B Splicing Isoform 532;
Function
Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:11239457, PubMed:16818610).

Participates in Wnt signaling (By similarity).
Biological Process
Adiponectin-activated signaling pathway Source: BHF-UCL
Cellular protein-containing complex assembly Source: BHF-UCL
Endothelial tube morphogenesis Source: BHF-UCL
Macroautophagy Source: Reactome
Mitotic chromosome condensation Source: Reactome
Negative regulation of blood vessel endothelial cell migration Source: BHF-UCL
Negative regulation of cell population proliferation Source: BHF-UCL
Neutrophil degranulation Source: Reactome
Peptidyl-threonine phosphorylation Source: CAFA
Phosphatidylcholine biosynthetic process Source: Reactome
Positive regulation of activin receptor signaling pathway Source: BHF-UCL
Positive regulation of pathway-restricted SMAD protein phosphorylation Source: BHF-UCL
Protein folding Source: Reactome
Regulation of DNA binding Source: BHF-UCL
Regulation of signal transduction by p53 class mediator Source: Reactome
Signal transduction Source: UniProtKB
Wnt signaling pathway Source: UniProtKB-KW
Cellular Location
Cytosol; Extracellular exosome; Extracellular region; Nucleoplasm; Nucleus; Cytoplasm; Ficolin-1-rich granule lumen; Protein kinase CK2 complex; Secretory granule lumen
Involvement in disease
Poirier-Bienvenu neurodevelopmental syndrome (POBINDS):
An autosomal dominant neurodevelopmental disorder characterized by onset of seizures in infancy, developmental delay, impaired intellectual development, and poor or absent speech.
PTM
Phosphorylated by alpha subunit.

Wilke, M. V., Oliveira, B. M., Pereira, A., Doriqui, M. J. R., Kok, F., & Souza, C. F. (2022). Two different presentations of de novo variants of CSNK2B: two case reports. Journal of Medical Case Reports, 16(1), 1-6.

Selvam, P., Jain, A., Cheema, A., Atwal, H., Forghani, I., & Atwal, P. S. (2021). Poirier–Bienvenu neurodevelopmental syndrome: A report of a patient with a pathogenic variant in CSNK2B with abnormal linear growth. American Journal of Medical Genetics Part A, 185(2), 539-543.

Yu, S., Hu, Q., Fan, K., Yang, C., & Gao, Y. (2021). CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling. Journal of Cell Communication and Signaling, 15(3), 383-392.

Yu, S., Li, L., Cai, H., He, B., Gao, Y., & Li, Y. (2021). Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression. Journal of Experimental & Clinical Cancer Research, 40(1), 1-16.

Yang, S., Wu, L., Liao, H., Lu, X., Zhang, X., Kuang, X., & Yang, L. (2021). Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation. neurogenetics, 22(4), 323-332.

Li, J., Gao, K., Cai, S., Liu, Y., Wang, Y., Huang, S., ... & Jiang, Y. (2019). Germline de novo variants in CSNK2B in Chinese patients with epilepsy. Scientific reports, 9(1), 1-8.

Nakashima, M., Tohyama, J., Nakagawa, E., Watanabe, Y., Siew, C. N. G., Kwong, C. S., ... & Matsumoto, N. (2019). Identification of de novo CSNK2A1 and CSNK2B variants in cases of global developmental delay with seizures. Journal of human genetics, 64(4), 313-322.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-CSNK2B Recombinant Antibody (CBXC-2709)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare